| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.6M | -36.5% |
| Cost of Revenue | $3.7M | -21.5% |
| Gross Profit | $1.9M | -53.8% |
| R&D Expense | $2.7M | -2.3% |
| SG&A Expense | $3.5M | -15.2% |
| Operating Income | -$7.4M | -20.7% |
| Interest Expense | $295K | -64.5% |
| Net Income | -$6.3M | +42.8% |
| EPS (Basic) | -$2.61 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $620K | -84.3% |
| Short-term Investments | $197K | -87.9% |
| Accounts Receivable | $664K | -78.1% |
| Inventory | $2.5M | +114.2% |
| Current Assets | $5.9M | -45.8% |
| Total Assets | $11.2M | -24.3% |
| Current Liabilities | $6.9M | +11.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.6M | +15.3% |
| Capital Expenditures | $9K | — |
| Investing Cash Flow | $3.8M | +194.7% |
| Financing Cash Flow | $3.8M | -75.4% |
| Free Cash Flow | -$6.6M | — |
| -174.7% |
| EPS (Diluted) | -$2.61 | -174.7% |
| Long-term Debt |
| $148K |
| -96.8% |
| Total Liabilities | $10.8M | -6.2% |
| Stockholders' Equity | $229K | -93.0% |